Patents by Inventor Lühua Wang

Lühua Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of two microRNA moleculars in lung cancer prognosis and medicine preparation
    Patent number: 8664191
    Abstract: The present invention relates to use of two microRNAs in detection of lung cancer prognosis and in medicine preparation. Particularly, the invention relates to a composition comprising two small RNA molecules microRNA-150 and microRNA-886-3p, a device comprising the composition used in detection of lung cancer prognosis and in preparation of medicaments for inhibiting mammal and human lung cancer metastasis. Specifically, the expression levels of microRNA-150 and microRNA-886-3p can be used as the prognostic criteria of lung cancer prognosis, wherein high expression level of the gene combination indicates favorable therapeutic effect. The invention also relates to a device detecting the expression levels of microRNA-150 and microRNA-886-3p in mammalian and human lung cancer and a method for detecting the expression levels of microRNA-150 and microRNA-886-3p in samples.
    Type: Grant
    Filed: July 9, 2009
    Date of Patent: March 4, 2014
    Assignee: Cancer Institute, Chinese Academy of Medical Services
    Inventors: Qimin Zhan, Lühua Wang, Nan Bi, Yongmei Song, Jianzhong Cao, Wenyang Liu
  • USE OF TWO MICRORNA MOLECULARS IN LUNG CANCER PROGNOSIS AND MEDICINE PREPARATION
    Publication number: 20120220644
    Abstract: The present invention relates to use of two microRNAs in detection of lung cancer prognosis and in medicine preparation. Particularly, the invention relates to a composition comprising two small RNA molecules microRNA-150 and microRNA-886-3p, a device comprising the composition used in detection of lung cancer prognosis and in preparation of medicaments for inhibiting mammal and human lung cancer metastasis. Specifically, the expression levels of microRNA-150 and microRNA-886-3p can be used as the prognostic criteria of lung cancer prognosis, wherein high expression level of the gene combination indicates favorable therapeutic effect. The invention also relates to a device detecting the expression levels of microRNA-150 and microRNA-886-3p in mammalian and human lung cancer and a method for detecting the expression levels of microRNA-150 and microRNA-886-3p in samples.
    Type: Application
    Filed: July 9, 2009
    Publication date: August 30, 2012
    Applicant: CANCER INSTITUTE, CHINESE ACADEMY OF MEDICAL SCIENCES
    Inventors: Qimin Zhan, Lühua Wang, Nan Bi, Yongmei Song, Jianzhong Cao, Wenyang Liu